# Siamak Baharloo

> Siamak Baharloo is the Boston-area co-founder and CEO of Labviva, a procurement software company serving scientific research organizations. Trained in genetics at UCSF, he spent more than two decades in digital marketing and e-commerce at scientific suppliers before co-founding Labviva in 2017. His work connects scientific product information, purchasing and supplier access.

- **Role:** Co-founder and CEO at Labviva
- **Organizations:** Labviva, Sartorius, Thermo Fisher Scientific, Life Technologies, MilliporeSigma
- **Education:** PhD in genetics, University of California, San Francisco
- **Known for:** Co-founded Labviva and led the company as CEO., Named co-inventor on published patent application US20120203661A1, E-Commerce Systems and Methods., Led Labviva through its January 2025 Series B, which brought company-reported total funding to $55 million.

## Career timeline

- **1994-2000** — Attended the University of California, San Francisco; his public biographies identify a doctorate in genetics.
- **2009** — Identified as Director of eBusiness at Millipore in a February product announcement.
- **2011** — Named as a co-inventor on an e-commerce systems and methods patent application assigned to Life Technologies; the application was published in 2012.
- **2014** — Identified as Head of Global eBusiness at Sartorius in an October product-information-management announcement.
- **2017** — Co-founded Labviva with Nicholas Rioux and Aaron Miramontes.
- **2018** — Labviva publicly launched its scientific digital marketplace in December.
- **2019** — Participated in the MIT Platform Strategy Summit’s discussion of incumbent companies and marketplaces.
- **2021** — Labviva announced an $8 million seed round and opened a Boston headquarters.
- **2023** — Labviva announced $20 million in Series A funding led by Biospring Partners.
- **2025** — Labviva announced a $25 million Series B, followed by its London international headquarters.
- **2026** — Labviva announced the Agentic Crew architecture in June.

## Achievements

- Co-founded Labviva and led the company as CEO.
- Named co-inventor on published patent application US20120203661A1, E-Commerce Systems and Methods.
- Led Labviva through its January 2025 Series B, which brought company-reported total funding to $55 million.
- Helped expand Labviva into Europe with a London international headquarters announced in May 2025.

## Latest updates

- **2026-06** — Labviva announced its Agentic Crew architecture on June 24 after a June 4 summit preview; analytics and inventory agents were identified as in development and unavailable for commercial purchase at launch.
- **2025-12** — His Forbes Technology Council profile lists his article How Neutral Platforms Are Rewriting The Rules Of Supply Chain Control, dated December 5.
- **2025-05** — Labviva announced its London international headquarters and appointed Carlo Iannicola as general manager of Europe.

## Links

- Website: https://labviva.com/about-labviva
- LinkedIn: https://www.linkedin.com/in/siamak-baharloo-a4bb4831

---

Profile page: https://yespress.io/siamak-baharloo
Published by YesPress — https://yespress.io
Last updated: 2026-10-25